A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH)
Clinical trial NCT04783181 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04783181
- Sponsor
- Adrenas Therapeutics Inc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-01
- Primary completion
- 2029-02-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.